Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Nov 2020 for PROVECTUS BIOPHARMACEUTICALS, INC..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
John Lacy III: trading record in brief
One trade, one date: on 12 November 2020, John Lacy III disclosed a share grant in Provectus Biopharmaceuticals, Inc. No broader history exists yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Lacy III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 100,000 shares0Common StockSEC:0001493152-20-021179:0
1 of 1 declaration